Sodium-Glucose Linked Cotransporter-2 Inhibition Does Not Attenuate Disease Progression in the Rat Remnant Kidney Model of Chronic Kidney Disease-Reference-Cited by-同舟云学术

Sodium-Glucose Linked Cotransporter-2 Inhibition Does Not Attenuate Disease Progression in the Rat Remnant Kidney Model of Chronic Kidney Disease

Published:2016-01-07 Issue:1 Volume:11 Page:e0144640
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Zhang Yanling,Thai Kerri,Kepecs David M.,Gilbert Richard E.

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference53 articles.

1. Dietary protein intake and the progressive nature of kidney disease: the role of hemodynamically mediated glomerular injury in the pathogenesis of progressive glomerular sclerosis in aging, renal ablation, and intrinsic renal disease;BM Brenner;N Engl J Med,1982

2. Hemodynamic effects of angiotensin II in the kidney;A Toke;Contrib Nephrol,2001

3. Effect of blood glucose control on increased glomerular filtration rate and kidney size in insulin-dependent diabetes;MJ Wiseman;N Engl J Med,1985

4. Impaired myogenic responsiveness of the afferent arteriole in streptozotocin-induced diabetic rats: role of eicosanoid derangements;K Hayashi;J Am Soc Nephrol,1992

5. Effect of exogenous and endogenous angiotensin II in the isolated perfused rat kidney;M Davalos;Am J Physiol,1978

Cited by 57 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Gliflozins in the Treatment of Non-diabetic Experimental Cardiovascular Diseases;Physiological Research;2024-08-31

2. Sodium glucose transporter 2 inhibitors: Will these drugs benefit non‐diabetic veterinary patients with cardiac and kidney diseases?;Journal of Veterinary Pharmacology and Therapeutics;2024-07-13

3. Hepatoprotective and cardioprotective effects of empagliflozin in spontaneously hypertensive rats fed a high-fat diet;Biomedicine & Pharmacotherapy;2024-05

4. SGLT2 Inhibitors and Kidney Protection: Mechanisms Beyond Tubuloglomerular Feedback;Kidney360;2024-03-25

5. Sodium Glucose Cotransporter-2 Inhibitors in Non-Diabetic Kidney Disease: Evidence in Experimental Models;Pharmaceuticals;2024-03-11